Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis

Tamako Shinohara, Yasuhiro Nemoto, Takanori Kanai, Kaori Kameyama, Ryuichi Okamoto, Kiichiro Tsuchiya, Tetsuya Nakamura, Teruji Totsuka, Koichi Ikuta, Mamoru Watanabe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We have previously demonstrated that IL-7 is essential for the persistence of colitis as a survival factor of colitogenic IL-7Rα-expressing memory CD4+ T cells. Because IL-7Rα is broadly expressed on various immune cells, it is possible that the persistence of colitogenic CD4+ T cells is affected by other IL-7Rα-expressing non-T cells. To test this hypothesis, we conducted two adoptive transfer colitis experiments using IL-7Rα-/- CD4+CD25- donor cells and IL-7Rα-/- x RAG-2-/- recipient mice, respectively. First, IL-7Rα expression on colitic lamina propria (LP) CD4+ T cells was significantly higher than on normal LP CD4+ T cells, whereas expression on other colitic LP immune cells, (e.g., NK cells, macrophages, myeloid dendritic cells) was conversely lower than that of paired LP cells in normal mice, resulting in predominantly higher expression of IL-7Rα on colitogenic LP CD4+ cells, which allows them to exclusively use IL-7. Furthermore, RAG-2-/- mice transferred with IL-7Rα-/- CD4+CD25- T cells did not develop colitis, although LP CD4+ T cells from mice transferred with IL-7Rα-/- CD4+CD25- T cells were differentiated to CD4+ CD44highCD62L- effector-memory T cells. Finally, IL-7Rα-/- x RAG-2 -/- mice transferred with CD4+CD25- T cells developed colitis similar to RAG-2-/- mice transferred with CD4 +CD25- T cells. These results suggest that IL-7Rα expression on colitogenic CD4+ T cells, but not on other cells, is essential for the development of chronic colitis. Therefore, therapeutic approaches targeting the IL-7/IL-7R signaling pathway in colitogenic CD4 + T cells may be feasible for the treatment of inflammatory bowel diseases. Copyright

Original languageEnglish
Pages (from-to)2623-2632
Number of pages10
JournalJournal of Immunology
Volume186
Issue number4
DOIs
Publication statusPublished - 2011 Feb 15

Fingerprint

Interleukin-7 Receptors
Colitis
T-Lymphocytes
Mucous Membrane
Interleukin-7
Adoptive Transfer
Myeloid Cells
Inflammatory Bowel Diseases
Natural Killer Cells
Dendritic Cells

ASJC Scopus subject areas

  • Immunology

Cite this

Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis. / Shinohara, Tamako; Nemoto, Yasuhiro; Kanai, Takanori; Kameyama, Kaori; Okamoto, Ryuichi; Tsuchiya, Kiichiro; Nakamura, Tetsuya; Totsuka, Teruji; Ikuta, Koichi; Watanabe, Mamoru.

In: Journal of Immunology, Vol. 186, No. 4, 15.02.2011, p. 2623-2632.

Research output: Contribution to journalArticle

Shinohara, Tamako ; Nemoto, Yasuhiro ; Kanai, Takanori ; Kameyama, Kaori ; Okamoto, Ryuichi ; Tsuchiya, Kiichiro ; Nakamura, Tetsuya ; Totsuka, Teruji ; Ikuta, Koichi ; Watanabe, Mamoru. / Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis. In: Journal of Immunology. 2011 ; Vol. 186, No. 4. pp. 2623-2632.
@article{464c09db8718469aa5aac1897f8762fe,
title = "Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis",
abstract = "We have previously demonstrated that IL-7 is essential for the persistence of colitis as a survival factor of colitogenic IL-7Rα-expressing memory CD4+ T cells. Because IL-7Rα is broadly expressed on various immune cells, it is possible that the persistence of colitogenic CD4+ T cells is affected by other IL-7Rα-expressing non-T cells. To test this hypothesis, we conducted two adoptive transfer colitis experiments using IL-7Rα-/- CD4+CD25- donor cells and IL-7Rα-/- x RAG-2-/- recipient mice, respectively. First, IL-7Rα expression on colitic lamina propria (LP) CD4+ T cells was significantly higher than on normal LP CD4+ T cells, whereas expression on other colitic LP immune cells, (e.g., NK cells, macrophages, myeloid dendritic cells) was conversely lower than that of paired LP cells in normal mice, resulting in predominantly higher expression of IL-7Rα on colitogenic LP CD4+ cells, which allows them to exclusively use IL-7. Furthermore, RAG-2-/- mice transferred with IL-7Rα-/- CD4+CD25- T cells did not develop colitis, although LP CD4+ T cells from mice transferred with IL-7Rα-/- CD4+CD25- T cells were differentiated to CD4+ CD44highCD62L- effector-memory T cells. Finally, IL-7Rα-/- x RAG-2 -/- mice transferred with CD4+CD25- T cells developed colitis similar to RAG-2-/- mice transferred with CD4 +CD25- T cells. These results suggest that IL-7Rα expression on colitogenic CD4+ T cells, but not on other cells, is essential for the development of chronic colitis. Therefore, therapeutic approaches targeting the IL-7/IL-7R signaling pathway in colitogenic CD4 + T cells may be feasible for the treatment of inflammatory bowel diseases. Copyright",
author = "Tamako Shinohara and Yasuhiro Nemoto and Takanori Kanai and Kaori Kameyama and Ryuichi Okamoto and Kiichiro Tsuchiya and Tetsuya Nakamura and Teruji Totsuka and Koichi Ikuta and Mamoru Watanabe",
year = "2011",
month = "2",
day = "15",
doi = "10.4049/jimmunol.1000057",
language = "English",
volume = "186",
pages = "2623--2632",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis

AU - Shinohara, Tamako

AU - Nemoto, Yasuhiro

AU - Kanai, Takanori

AU - Kameyama, Kaori

AU - Okamoto, Ryuichi

AU - Tsuchiya, Kiichiro

AU - Nakamura, Tetsuya

AU - Totsuka, Teruji

AU - Ikuta, Koichi

AU - Watanabe, Mamoru

PY - 2011/2/15

Y1 - 2011/2/15

N2 - We have previously demonstrated that IL-7 is essential for the persistence of colitis as a survival factor of colitogenic IL-7Rα-expressing memory CD4+ T cells. Because IL-7Rα is broadly expressed on various immune cells, it is possible that the persistence of colitogenic CD4+ T cells is affected by other IL-7Rα-expressing non-T cells. To test this hypothesis, we conducted two adoptive transfer colitis experiments using IL-7Rα-/- CD4+CD25- donor cells and IL-7Rα-/- x RAG-2-/- recipient mice, respectively. First, IL-7Rα expression on colitic lamina propria (LP) CD4+ T cells was significantly higher than on normal LP CD4+ T cells, whereas expression on other colitic LP immune cells, (e.g., NK cells, macrophages, myeloid dendritic cells) was conversely lower than that of paired LP cells in normal mice, resulting in predominantly higher expression of IL-7Rα on colitogenic LP CD4+ cells, which allows them to exclusively use IL-7. Furthermore, RAG-2-/- mice transferred with IL-7Rα-/- CD4+CD25- T cells did not develop colitis, although LP CD4+ T cells from mice transferred with IL-7Rα-/- CD4+CD25- T cells were differentiated to CD4+ CD44highCD62L- effector-memory T cells. Finally, IL-7Rα-/- x RAG-2 -/- mice transferred with CD4+CD25- T cells developed colitis similar to RAG-2-/- mice transferred with CD4 +CD25- T cells. These results suggest that IL-7Rα expression on colitogenic CD4+ T cells, but not on other cells, is essential for the development of chronic colitis. Therefore, therapeutic approaches targeting the IL-7/IL-7R signaling pathway in colitogenic CD4 + T cells may be feasible for the treatment of inflammatory bowel diseases. Copyright

AB - We have previously demonstrated that IL-7 is essential for the persistence of colitis as a survival factor of colitogenic IL-7Rα-expressing memory CD4+ T cells. Because IL-7Rα is broadly expressed on various immune cells, it is possible that the persistence of colitogenic CD4+ T cells is affected by other IL-7Rα-expressing non-T cells. To test this hypothesis, we conducted two adoptive transfer colitis experiments using IL-7Rα-/- CD4+CD25- donor cells and IL-7Rα-/- x RAG-2-/- recipient mice, respectively. First, IL-7Rα expression on colitic lamina propria (LP) CD4+ T cells was significantly higher than on normal LP CD4+ T cells, whereas expression on other colitic LP immune cells, (e.g., NK cells, macrophages, myeloid dendritic cells) was conversely lower than that of paired LP cells in normal mice, resulting in predominantly higher expression of IL-7Rα on colitogenic LP CD4+ cells, which allows them to exclusively use IL-7. Furthermore, RAG-2-/- mice transferred with IL-7Rα-/- CD4+CD25- T cells did not develop colitis, although LP CD4+ T cells from mice transferred with IL-7Rα-/- CD4+CD25- T cells were differentiated to CD4+ CD44highCD62L- effector-memory T cells. Finally, IL-7Rα-/- x RAG-2 -/- mice transferred with CD4+CD25- T cells developed colitis similar to RAG-2-/- mice transferred with CD4 +CD25- T cells. These results suggest that IL-7Rα expression on colitogenic CD4+ T cells, but not on other cells, is essential for the development of chronic colitis. Therefore, therapeutic approaches targeting the IL-7/IL-7R signaling pathway in colitogenic CD4 + T cells may be feasible for the treatment of inflammatory bowel diseases. Copyright

UR - http://www.scopus.com/inward/record.url?scp=79951828164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951828164&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1000057

DO - 10.4049/jimmunol.1000057

M3 - Article

VL - 186

SP - 2623

EP - 2632

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -